Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

about

Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017.

P2860

Q55514852-E8593F1A-7690-4829-BED1-A32C8F9882C7

P2860

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

Item

http://www.wikidata.org/entity/Q47127905

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@en

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@nl

type

Item

label

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@en

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@nl

prefLabel

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@en

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@nl

P1476

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

@en

P2093

Alexandra F Freeman

http://www.w3.org/2001/XMLSchema#string

Amy P Hsu

http://www.w3.org/2001/XMLSchema#string

Berenice Rösler

http://www.w3.org/2001/XMLSchema#string

Christa S Zerbe

http://www.w3.org/2001/XMLSchema#string

Elizabeth P Sampaio

http://www.w3.org/2001/XMLSchema#string

Frank L van de Veerdonk

http://www.w3.org/2001/XMLSchema#string

Hye Sun Kuehn

http://www.w3.org/2001/XMLSchema#string

Kristina M Brooks

http://www.w3.org/2001/XMLSchema#string

Lindsey B Rosen

http://www.w3.org/2001/XMLSchema#string

Mihai G Netea

http://www.w3.org/2001/XMLSchema#string

P2860

A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization

PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90

STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

Treatment of Experimental Candida Sepsis with a Janus Kinase Inhibitor Controls Inflammation and Prolongs Survival

Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome

Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Risk Factors for Disseminated Coccidioidomycosis, United States.

Staurosporine Induces Filamentation in the Human Fungal Pathogen Candida albicans via Signaling through Cyr1 and Protein Kinase A.

P304

ofx202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFX202

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gulbu Uzel

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226168

http://www.w3.org/2001/XMLSchema#string

P932

5714179

http://www.w3.org/2001/XMLSchema#string

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

about

P2860

P2860

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932